Rhinorrhoea: FDA reporting patterns
63,603 FDA FAERS reports mention Rhinorrhoea. 26,341 reports have a serious outcome flag.
Medicines named as suspect
- Etanercept: 3,839 reports
- Dupilumab: 3,718 reports
- Evolocumab: 3,589 reports
- Adalimumab: 3,549 reports
- Fluticasone: 1,888 reports
- Omalizumab: 1,665 reports
- Infliximab: 1,599 reports
- Tofacitinib: 1,597 reports
- Secukinumab: 1,509 reports
- Methotrexate: 1,426 reports
- Prednisone: 1,230 reports
- Lenalidomide: 1,223 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.